Transcript
The KRAS gene helps to regulate cell proliferation, differentiation, and survival.
KRAS G12C is a specific KRAS mutation that results in the substitution of glycine for cysteine at position twelve of the KRAS protein.
The KRAS G12C mutation is one of the most common non small lung cancer (NSCLC) molecular biomarkers, occurring in 13% of patients from western ...populations.
Biomarker testing can determine if a patient's NSCLC harbors the KRAS G12C mutation.
